Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:42 PM
Ignite Modification Date:
2025-12-24 @ 11:42 PM
NCT ID:
NCT04214951
Eligibility Criteria:
Inclusion Criteria:
1.18 years or older
2.Primary ITP
3.Platelet count ≤ 30 × 109/l
4.Normal neutrophils, reticulocyte count, creatinine and liver enzyme values
5.Available follow-up of 2 months at least for each period
6.Failed initial glucocorticosteroid treatment
7.Unwillingness to accept splenectomy or failed splenectomy
\-
Exclusion Criteria:
1. HIV, hepatitis B or C, Helicobacter pylori infection
2. Malignancy
3. Congenital or acquired immunologic deficit
4. History of thrombosis plus two or more risk factors
5. Nursing or pregnant women
6. Abnormal liver and renal functions: AST/ALT/total bilirubin ≥1.5 × ULN, creatinine ≥1.5 mg/dl
7. Severe heart and lung dysfunctions -
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT04214951
Study Brief:
Protocol Section:
NCT04214951